Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Delattre, O."" wg kryterium: Wszystkie pola


Tytuł :
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Autorzy :
Andrianteranagna M; INSERM, U830, Pediatric Translational Research, PSL Research University, Institut Curie, Paris, France.; INSERM, U900, F-75005, Paris, France.; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, F-75006, Paris, France.
Cyrta J; Department of Pathology, Institut Curie, PSL Research University, Paris, France.
Masliah-Planchon J; Genetics Unit, Department of Tumor Biology, Institut Curie, PSL Research University, Paris, France.
Nemes K; Paediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Germany.
Corsia A; INSERM, U830, Pediatric Translational Research, PSL Research University, Institut Curie, Paris, France.
Leruste A; INSERM, U830, Pediatric Translational Research, PSL Research University, Institut Curie, Paris, France.
Holdhof D; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, 20246, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Germany.
Kordes U; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, 20246, Hamburg, Germany.
Orbach D; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), PSL Research University, Institut Curie, Paris, France.
Corradini N; Centre Léon Bérard, Institut d'Hématologie et d'Oncologie pédiatrique, Lyon, France.
Entz-Werle N; Pediatric and Adolescent Oncology, IHOP, Centre Léon Bérard, Lyon, France.
Pierron G; Genetics Unit, Department of Tumor Biology, Institut Curie, PSL Research University, Paris, France.
Castex MP; Department of Pediatric and Adolescent Unity Oncology, Toulouse University Hospital, Toulouse, France.
Brouchet A; Department of Pathology, Insititut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Weingertner N; Department of Pathology, Strasbourg University Hospital, Strasbourg, France.
Ranchère D; Department of Pathology, Centre Léon Bérard, Lyon, France.
Fréneaux P; Department of Pathology, Institut Curie, PSL Research University, Paris, France.
Delattre O; Genetics Unit, Department of Tumor Biology, Institut Curie, PSL Research University, Paris, France.
Bush J; Division of Anatomical Pathology, British Columbia Children's Hospital and Women's Hospital and Health Center, Vancouver, British Columbia, Canada.
Leary A; Gynecological Cancer Unit, Department of Medicine, Gustave Roussy, France; INSERM U981, Gustave Roussy, Villejuif, France.
Frühwald MC; Paediatrics and Adolescent Medicine, Swabian Children's Cancer Center, University Medical Center Augsburg, Germany.
Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, 20246, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Germany.; Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, 20246, Hamburg, Germany.
Servant N; INSERM, U900, F-75005, Paris, France.; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, F-75006, Paris, France.; Institut Curie, PSL Research University, F-75005, Paris, France.
Bourdeaut F; INSERM, U830, Pediatric Translational Research, PSL Research University, Institut Curie, Paris, France.; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), PSL Research University, Institut Curie, Paris, France.
Pokaż więcej
Źródło :
The Journal of pathology [J Pathol] 2021 May 17. Date of Electronic Publication: 2021 May 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.
Autorzy :
Surdez D; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France. Electronic address: .
Zaidi S; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
Grossetête S; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
Laud-Duval K; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
Ferre AS; INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer and Université de Paris, Imagine Institute, 75005 Paris, France.
Mous L; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
Vourc'h T; UMR 168, Biology Inspired Physics at Mesoscales, PSL Research University, Institut Curie Research Centre, 75005 Paris, France.
Tirode F; Univ Lyon, Université Claude Bernard Lyon 1, CNRS 5286, INSERM U1052, Cancer Research Center of Lyon, 69008 Lyon, France.
Pierron G; Unité de Génétique Somatique, Service d'oncogénétique, Institut Curie, Centre Hospitalier, 75005 Paris, France.
Raynal V; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Université, Institut Curie Research Centre, 75005 Paris, France.
Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, PSL Université, Institut Curie Research Centre, 75005 Paris, France.
Brunet E; INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer and Université de Paris, Imagine Institute, 75005 Paris, France.
Hill V; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France.
Delattre O; INSERM U830, Équipe Labellisée LNCC, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Centre, Institut Curie Research Centre, 75005 Paris, France; Unité de Génétique Somatique, Service d'oncogénétique, Institut Curie, Centre Hospitalier, 75005 Paris, France. Electronic address: olivier.delattre@curie.fr.
Pokaż więcej
Źródło :
Cancer cell [Cancer Cell] 2021 Apr 28. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Transfer of distal peroneus longus tendon to tibialis anterior by retrograde fixation to treat spastic equinovarus foot in adults: Surgical Technique and Preliminary Results.
Autorzy :
Delattre O; Centre Hospitalier Universitaire, 97200 Fort de France, France.
Sellenet T; Centre Hospitalier Universitaire, 97200 Fort de France, France.
Barnay JL; Centre Hospitalier Universitaire, 97200 Fort de France, France.
Chevillotte T; Centre Hospitalier Universitaire, 97200 Fort de France, France.
De Tienda M; Centre Hopitalier Universitaire Necker enfants malades, 149, rue de Sèvres, 75015 Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Orthopaedics & traumatology, surgery & research : OTSR [Orthop Traumatol Surg Res] 2021 Apr 14, pp. 102935. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cells expansion.
Autorzy :
Astori A; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Matherat G; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Munoz I; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Gautier EF; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Surdez D; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris.
Zermati Y; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris.
Verdier F; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris.
Zaidi S; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris.
Feuillet V; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris.
Kadi A; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris.
Lauret E; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Delattre O; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris.
Lefèvre C; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris.
Fontenay M; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Service d'Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Paris.
Ségal-Bendirdjian E; INSERM UMR-S 1124, Team: Cellular Homeostasis Cancer and Therapies, Université de Paris, Paris.
Dusanter-Fourt I; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Bouscary D; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Hermine O; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France; Université de Paris, Institut Imagine, INSERM, CNRS, F-75015, Paris.
Mayeux P; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris.
Pendino F; Université de Paris, Institut Cochin, INSERM, CNRS, F-75014 Paris, France; Laboratory of Excellence GR-ex, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris. .
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2020 Nov 26; Vol. Online ahead of print. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN -Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Autorzy :
Ambros IM; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Tonini GP; Paediatric Research Institute, Fondazione Città della Speranza, Neuroblastoma Laboratory, Padua, Italy.
Pötschger U; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Gross N; Pediatric Oncology Research, Department of Pediatrics, University Hospital, Lausanne, Switzerland.
Mosseri V; Service de Biostatistiques, Institut Curie, Paris, France.
Beiske K; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Berbegall AP; Department of Pathology, Medical School, University of Valencia-Fundación de Investigación del Hospital Clínico Universitario de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Bénard J; Département de Biologie et de Pathologie Médicales, Service de Pathologie Moléculaire, Institut Gustave Roussy, Villejuif, France.
Bown N; Northern Genetics Service, Newcastle upon Tyne, United Kingdom.
Caron H; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands.
Combaret V; Centre Léon Bérard, Laboratoire de Recherche Translationnelle, Lyon, France.
Couturier J; Unité de Génétique Somatique et Cytogénétique, Institut Curie, Paris, France.
Defferrari R; Department of Pathology, Istituto G. Gaslini, Genoa, Italy.
Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Paris, France.
Jeison M; Ca-Cytogenetic Laboratory, Pediatric Hematology Oncology Department, Schneider Children's Medical Center of Israel, Petah Tikvah, Israel.
Kogner P; Childhood Cancer Research Unit, Karolinska Institutet, Astrid Lindgren Children's Hospital, Stockholm, Sweden.
Lunec J; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Marques B; Centro de Genética Humana, Instituto Nacional de Saude doutor Ricardo Jorge, Lisbon, Portugal.
Martinsson T; Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.
Mazzocco K; Department of Pathology, Istituto G. Gaslini, Genoa, Italy.
Noguera R; Department of Pathology, Medical School, University of Valencia-Fundación de Investigación del Hospital Clínico Universitario de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Schleiermacher G; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Paris, France.; Département de Pédiatrie, Institut Curie, Paris, France.
Valent A; Département de Biologie et de Pathologie Médicales, Service de Pathologie Moléculaire, Institut Gustave Roussy, Villejuif, France.
Van Roy N; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Villamon E; Department of Pathology, Medical School, University of Valencia-Fundación de Investigación del Hospital Clínico Universitario de Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Janousek D; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Pribill I; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Glogova E; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
Attiyeh EF; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Hogarty MD; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA.
Monclair TF; Section for Paediatric Surgery, Division of Surgery, Rikshospitalet University Hospital, Oslo, Norway.
Holmes K; Department of Paediatric Surgery, St George's Hospital, London, UK.
Valteau-Couanet D; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Villejuif, France.
Castel V; Unidad de Oncologia Pediatrica Hospital Universitario La Fe, Valencia, Spain.
Tweddle DA; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Park JR; Seattle Children's Hospital and University of Washington School of Medicine, Seattle, WA.
Cohn S; Department of Pediatrics, The University of Chicago, Chicago, IL.
Ladenstein R; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
Beck-Popovic M; Pediatric Hematology Oncology Unit, University Hospital of Lausanne, Lausanne, Switzerland.
De Bernardi B; Department of Paediatric Haematology and Oncology, Giannina Gaslini Children's Hospital, Genova, Italy.
Michon J; Département de Pédiatrie, Institut Curie, Paris, France.
Pearson ADJ; Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
Ambros PF; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.; Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 01; Vol. 38 (31), pp. 3685-3697. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Chromosome Aberrations*
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 11*
N-Myc Proto-Oncogene Protein/*genetics
Neuroblastoma/*genetics
Age Factors ; Clinical Trials as Topic ; Diploidy ; Gene Amplification ; Genomics ; Humans ; Infant ; Neoplasm Staging ; Neuroblastoma/pathology ; Neuroblastoma/surgery ; Prognosis ; Progression-Free Survival ; Survival Rate
Czasopismo naukowe
Tytuł :
Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity.
Autorzy :
Manzella G; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Schreck LD; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Breunis WB; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.; Princess Máxima Center for Pediatric Oncology, Uppsalalaan 8, 3584, CT, Utrecht, The Netherlands.
Molenaar J; Princess Máxima Center for Pediatric Oncology, Uppsalalaan 8, 3584, CT, Utrecht, The Netherlands.
Merks H; Princess Máxima Center for Pediatric Oncology, Uppsalalaan 8, 3584, CT, Utrecht, The Netherlands.
Barr FG; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Sun W; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Römmele M; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Zhang L; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Tchinda J; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Ngo QA; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Bode P; University Hospital Zurich, Institute of Surgical Pathology, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland.
Delattre O; France INSERM U830, Équipe Labellisé LNCC, PSL Université, SIREDO Oncology Centre, Institut Curie, Paris, France.
Surdez D; France INSERM U830, Équipe Labellisé LNCC, PSL Université, SIREDO Oncology Centre, Institut Curie, Paris, France.
Rekhi B; Tata Memorial Hospital, Department of Pathology, Dr E.B. road, Parel, Mumbai, 400012, India.
Niggli FK; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Schäfer BW; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland. .
Wachtel M; University Children's Hospital, Department of Oncology and Children's Research Center, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Sep 15; Vol. 11 (1), pp. 4629. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Drug Screening Assays, Antitumor/*methods
Proto-Oncogene Proteins c-akt/*antagonists & inhibitors
Rhabdomyosarcoma/*metabolism
Animals ; Biological Specimen Banks ; Gene Expression Profiling ; Humans ; Phenotype ; Protein Kinase Inhibitors ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Rhabdomyosarcoma/drug therapy ; Rhabdomyosarcoma/genetics ; Tumor Cells, Cultured/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
Autorzy :
Lin SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Surdez D; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
Reynaud S; SIREDO Oncology Centre, Institut Curie, Paris, France.
Mirabeau O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Rubio RA; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.
Zaidi S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Grossetête-Lalami S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Ballet S; SIREDO Oncology Centre, Institut Curie, Paris, France.
Lapouble E; SIREDO Oncology Centre, Institut Curie, Paris, France.
Laurence V; SIREDO Oncology Centre, Institut Curie, Paris, France.
Michon J; SIREDO Oncology Centre, Institut Curie, Paris, France.
Pierron G; SIREDO Oncology Centre, Institut Curie, Paris, France.
Kovar H; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Kontny U; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Uniklinik RWTH Aachen, Aachen, Germany.
González-Neira A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Alonso J; Unidad de Tumores Solidos Infantiles (IIER-ISCIII) & Centro de Investigación Biomédica en Red de Enfermedades Raras (CB06/07/1009; CIBERER-ISCIII), Instituto de Salud Carlos III, Majadahonda, Spain.
Patino-Garcia A; Laboratory of Pediatrics, University Clinic of Navarra, Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.
Corradini N; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
Bérard PM; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
Miller J; Information Management Services, Inc., Calverton, MD, United States of America.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Carter BD; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, United States of America.
Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Burdett L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Jones K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Manning M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Wyatt K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Zhou W; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Cox DG; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.
Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
Leisenring WM; Cancer Prevention and Clinical Statistics Programs, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, United States of America.
Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
Kulozik AE; Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center, University of Heidelberg, Heidelberg, Germany.
Kriebel J; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; German Center for Diabetes Research (DZD), München, Neuherberg, Germany.
Meitinger T; German Research Center for Environmental Health, Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Human Genetics, Technische Universität München, Munich, Germany.
Metzler M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
Krumbholz M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
Hartmann W; Division of Translational Pathology, Gerhard-Domagk Institute of Pathology, University Hospital of Münster, Münster, Germany.
Strauch K; Institute of Genetic Epidemiology, LMU Munich, Munich, Germany.
Kirchner T; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Center Essen, Heidelberg, Germany.
Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Tirode F; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Delattre O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 03; Vol. 15 (9), pp. e0237792. Date of Electronic Publication: 2020 Sep 03 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Loci*
Genetic Predisposition to Disease*
Genetic Variation*
Germ Cells/*metabolism
Sarcoma, Ewing/*genetics
Genome-Wide Association Study ; Humans ; Linkage Disequilibrium/genetics ; Odds Ratio ; Polymorphism, Single Nucleotide/genetics
Czasopismo naukowe
Tytuł :
The usefulness of a short stay geriatric unit post emergency department for the facilitation of in-hospital care of elderly subjects.
Autorzy :
Moyet J; Departments of Geriatric Medicine.
Douay B; Emergency.
Delattre O; Departments of Geriatric Medicine.
Hannat S; Departments of Geriatric Medicine.
Defouilloy C; Departments of Geriatric Medicine.
Bloch F; Departments of Geriatric Medicine.; Laboratory of Functional Neurosciences EA 4559, University Hospital of Amiens-Picardie, Amiens, France.
Pokaż więcej
Źródło :
European journal of emergency medicine : official journal of the European Society for Emergency Medicine [Eur J Emerg Med] 2020 Jun; Vol. 27 (3), pp. 230-231.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Autorzy :
Theruvath J; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Sotillo E; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Mount CW; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.
Graef CM; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Delaidelli A; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Heitzeneder S; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Labanieh L; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA.
Dhingra S; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Leruste A; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Xu P; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Mueller S; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Yecies DW; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Finetti MA; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Williamson D; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Johann PD; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Kool M; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.
Pfister S; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Hasselblatt M; Institute of Neuropathology, Münster University Hospital, Münster, Germany.
Frühwald MC; University Children's Hospital Augsburg, Swabian Children's Cancer Center, Augsburg, Germany.; EU-RHAB Registry Center, Augsburg, Germany.
Delattre O; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Surdez D; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Bourdeaut F; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Puget S; Paris University, Necker-Enfants Malades Hospital, Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, Paris, France.
Zaidi S; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Mitra SS; Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Cheshier S; Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Hospital and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Sorensen PH; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Monje M; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Institute for Stem Cell and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mackall CL; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. .; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. .; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2020 May; Vol. 26 (5), pp. 712-719. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
B7 Antigens/*immunology
Brain Neoplasms/*therapy
Cancer Vaccines/*administration & dosage
Immunotherapy, Adoptive/*methods
Rhabdoid Tumor/*therapy
Teratoma/*therapy
Adult ; Animals ; Brain/drug effects ; Brain/immunology ; Brain/pathology ; Brain Neoplasms/immunology ; Brain Neoplasms/pathology ; Cells, Cultured ; Child, Preschool ; Female ; Fetus/pathology ; Humans ; Infant ; Injections, Intraventricular ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Receptors, Chimeric Antigen/administration & dosage ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/immunology ; Rhabdoid Tumor/immunology ; Rhabdoid Tumor/pathology ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; T-Lymphocytes/transplantation ; Teratoma/immunology ; Teratoma/pathology ; Xenograft Model Antitumor Assays
SCR Disease Name :
Teratoid Tumor, Atypical
Czasopismo naukowe
Tytuł :
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
Autorzy :
Tanaka I; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Chakraborty A; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Saulnier O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Benoit-Pilven C; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vacher S; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Labiod D; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Lam EWF; Imperial College London, London, UK.
Bièche I; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Delattre O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Pouzoulet F; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Auboeuf D; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vagner S; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Dutertre M; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Mar 18; Vol. 48 (5), pp. 2676-2693.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Alternative Splicing/*genetics
Breast Neoplasms/*drug therapy
Doxorubicin/*therapeutic use
Proto-Oncogene Proteins/*metabolism
RNA-Binding Proteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Alternative Splicing/drug effects ; Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Doxorubicin/pharmacology ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Exons/genetics ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; MCF-7 Cells ; Mice, Nude ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Middle Aged ; Protein Isoforms/metabolism ; RNA Splice Sites/genetics ; S Phase/drug effects ; Spliceosomes/metabolism
Czasopismo naukowe
Tytuł :
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.
Autorzy :
Orth MF; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Hölting TLB; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Dallmayer M; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Department of Pediatrics, University Hospital Münster, 48149 Münster, Germany.
Wehweck FS; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Paul T; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Musa J; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
Baldauf MC; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Surdez D; INSERM Unit 830 'Genetics and Biology of Cancers', Institut Curie Research Center, 75248 Paris, France.
Delattre O; INSERM Unit 830 'Genetics and Biology of Cancers', Institut Curie Research Center, 75248 Paris, France.
Knott MML; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Romero-Pérez L; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Kasan M; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Cidre-Aranaz F; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Gerke JS; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Ohmura S; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Li J; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Marchetto A; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Henssen AG; Department of Pediatric Hematology/Oncology/BMT, Charité-University Medicine Berlin, 13353 Berlin, Germany.; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, 13125 Berlin, Germany.
Özen Ö; Department of Pathology, Başkent University Hospital, 06490 Ankara, Turkey.
Sugita S; Department of Surgical Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Hasegawa T; Department of Surgical Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Kanaseki T; Department of Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Bertram S; Institute of Pathology, University Hospital Essen, 45147 Essen, Germany.
Dirksen U; Pediatrics III, AYA Unit, West German Cancer Centre, University Hospital Essen, 45147 Essen, Germany.; German Cancer Consortium (DKTK), Partner site Essen, 45147 Essen, Germany.
Hartmann W; Division of Translational Oncology, Gerhard-Domagk-Institute for Pathology, University Hospital Münster, 48149 Münster, Germany.
Kirchner T; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, 80336 Munich, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, 80336 Munich, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Mar 10; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma.
Autorzy :
Louis-Brennetot C; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Delattre O; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Janoueix-Lerosey I; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France. Electronic address: .
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2020 Mar; Vol. 53, pp. 102702. Date of Electronic Publication: 2020 Mar 19.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Neural Crest*
Neuroblastoma*
Humans ; Hyaluronan Receptors ; Prognosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies